Executive influence on invention and commercialization: The moderating role of innovation radicalness

IF 1.1 Q4 BUSINESS
Barton M. Sharp, Dinesh N Iyer, Thomas H. Brush
{"title":"Executive influence on invention and commercialization: The moderating role of innovation radicalness","authors":"Barton M. Sharp, Dinesh N Iyer, Thomas H. Brush","doi":"10.1108/AJB-11-2016-0036","DOIUrl":null,"url":null,"abstract":"Purpose - The purpose of this paper is to expand the understanding of the “front end” of innovation by examining the influence of top executives, who allocate the resources and cultivate the culture in which inventions are born, on the innovation process. Design/methodology/approach - This paper suggests that the effect of executives on innovation can be better understood by explicitly separating innovation into the component processes of invention and commercialization. This allows us to consider how executive characteristics might have a different effect on technology development outcomes than they do on the subsequent transformation of those technologies into new products. The theory is tested on a sample of firms from the biomedical device industry. Findings - The findings indicate that top management team (TMT) age and tenure have no effect on the type of technologies a firm develops (radical vs incremental) but do significantly affect the efficiency with which new technologies are turned into new products in some contexts. TMT heterogeneity affects both the type of technologies developed in the firm and also their transformation to new products. Interestingly, the effect of executives on commercialization depends on the type of underlying technologies which the firm has developed. Originality/value - This paper contributes to the literatures on TMTs and innovation by offering a more granular explanation of how executives differentially impact the disaggregated stages of the innovation process, and thus also contributes to knowledge of the long-term innovation performance implications of executive leadership.","PeriodicalId":44116,"journal":{"name":"American Journal of Business","volume":"41 1","pages":"134-151"},"PeriodicalIF":1.1000,"publicationDate":"2017-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"7","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Business","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1108/AJB-11-2016-0036","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"BUSINESS","Score":null,"Total":0}
引用次数: 7

Abstract

Purpose - The purpose of this paper is to expand the understanding of the “front end” of innovation by examining the influence of top executives, who allocate the resources and cultivate the culture in which inventions are born, on the innovation process. Design/methodology/approach - This paper suggests that the effect of executives on innovation can be better understood by explicitly separating innovation into the component processes of invention and commercialization. This allows us to consider how executive characteristics might have a different effect on technology development outcomes than they do on the subsequent transformation of those technologies into new products. The theory is tested on a sample of firms from the biomedical device industry. Findings - The findings indicate that top management team (TMT) age and tenure have no effect on the type of technologies a firm develops (radical vs incremental) but do significantly affect the efficiency with which new technologies are turned into new products in some contexts. TMT heterogeneity affects both the type of technologies developed in the firm and also their transformation to new products. Interestingly, the effect of executives on commercialization depends on the type of underlying technologies which the firm has developed. Originality/value - This paper contributes to the literatures on TMTs and innovation by offering a more granular explanation of how executives differentially impact the disaggregated stages of the innovation process, and thus also contributes to knowledge of the long-term innovation performance implications of executive leadership.
行政对发明和商业化的影响:创新激进性的调节作用
目的-本文的目的是通过研究高层管理人员对创新过程的影响,扩大对创新“前端”的理解,他们分配资源并培养发明诞生的文化。设计/方法论/方法-本文建议,通过明确地将创新分为发明和商业化的组成过程,可以更好地理解高管对创新的影响。这使我们能够考虑执行特征如何对技术开发结果产生不同的影响,而不是对这些技术随后转化为新产品产生不同的影响。该理论在生物医学设备行业的公司样本上进行了测试。研究结果-研究结果表明,高层管理团队(TMT)的年龄和任期对公司开发的技术类型(激进还是增量)没有影响,但在某些情况下确实显著影响新技术转化为新产品的效率。TMT异质性既影响企业开发的技术类型,也影响其向新产品的转化。有趣的是,高管对商业化的影响取决于公司所开发的基础技术的类型。原创性/价值——本文通过更细致地解释高管如何以不同的方式影响创新过程的分解阶段,从而有助于了解高管领导力对长期创新绩效的影响,从而对TMTs和创新的文献做出了贡献。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
3
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信